Ghost authorship in industry-initiated randomised trials
about
What should be done to tackle ghostwriting in the medical literature?The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United StatesThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationGhost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry?Comparison of protocols and registry entries to published reports for randomised controlled trialsBan on Dextropropoxyphene is UnjustifiablePartisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapy.Systematic review on the primary and secondary reporting of the prevalence of ghostwriting in the medical literatureRecommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviewsA systematic review of research on the meaning, ethics and practices of authorship across scholarly disciplinesThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationGhostwriting: the dirty little secret of medical publishing that just got biggerObesity, the endocannabinoid system, and bias arising from pharmaceutical sponsorshipSPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsMedical ghost-writingMeasuring co-authorship and networking-adjusted scientific impactAuthors, ghosts, damned lies, and statisticiansSoft targets: nurses and the pharmaceutical industry.The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.Legal remedies for medical ghostwriting: imposing fraud liability on guest authors of ghostwritten articlesChallenging medical ghostwriting in US courts.Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols.Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publicationsGuest authors in an Iranian journal.Investigator experiences with financial conflicts of interest in clinical trials.What pharmacy practitioners need to know about ethics in scientific publishingExorcising ghostwriting…. Ghostwriting could potentially have serious repercussions for science and should therefore be treated as research misconductEconomics and industry do not mean ethical conduct in clinical trials.Criminals in the Citadel and Deceit all along the Watchtower: Irresponsibility, Fraud, and Complicity in the Search for Scientific Truth.The Impact of a Researcher's Structural Position on Scientific Performance: An Empirical AnalysisThe prevalence of honorary and ghost authorships in Iranian bio-medical journals and its associated factors.Sponsors' participation in conduct and reporting of industry trials: a descriptive study.Moving from opacity to transparency in pharmaceutical policy.Developing a guideline for clinical trial protocol content: Delphi consensus survey.Guidelines for randomized clinical trial protocol content: a systematic reviewAuthorship policies of scientific journals.The pulmonary hypertension academic research consortiumAuthorship: why not just toss a coin?Quantification of authors' contributions and eligibility for authorship: randomized study in a general medical journalSPIRIT 2013 Statement: defining standard protocol items for clinical trials.
P2860
Q21090135-39AC7F12-56F0-4CAB-932D-98CD6B4AAC51Q21090138-F393E43F-EB8A-4317-B2FC-AC85B9BAC86DQ21092360-8DF22F82-8886-495D-86EF-04B9ECE681B6Q21144665-755382D6-3F0D-4F7A-B492-7B2338CF01D9Q24235035-491BB5F3-4D80-4A74-B9DC-86D9950350A9Q24273327-0F27E33D-F60A-4011-8EA3-AC7E9D9D2A2AQ24289488-36623DB2-3300-4D39-896E-192958F759EEQ24561610-3F341770-3F8D-4260-9892-52CB55F302B2Q26783200-CC351180-3AED-4574-AD63-9452EBC6D292Q27002106-DD2E370E-1D87-4BA3-8CDE-585D668A3AFDQ27860581-A1829C01-7C63-422C-8C90-DD6FB09F75C1Q28119336-08347D96-1188-4773-A70F-BF61F0614E0AQ28475155-04EEED0E-F232-45D5-B7CD-E27A80E179CFQ28710019-C308AF74-4C19-4339-97E9-678699BB557DQ28744060-6E7346E3-E2D3-468D-ACA8-7C6570713292Q28757688-04445D8F-17A8-4FDC-A883-BDFCA93E5C4AQ33269401-2E8E2C02-7CCC-4F0E-9ED2-EA87A1FD15F1Q33318540-49A6639F-FB10-49C3-B63C-BF3CF5BFCD9DQ33583631-8687D6EA-2E1A-468A-A565-8F9847A0DB6AQ33987346-601BD0A9-A535-4E3E-AC01-F69A5B9A1213Q34145613-1B88275D-187D-45C3-9023-79C8D7A1E727Q34344163-45A9D395-F1F2-4667-B9D2-D7AF873722D2Q34402190-96B5B0DB-3D16-45C1-9E8B-7A3CC9072482Q34425684-077CCD78-3236-4A1C-B071-EA4EE8C6516AQ34540824-A66C2848-CE6B-4227-BDD0-20A87FBC649CQ34675662-06C46BFE-93DF-405A-BFD2-821A5AA43CE9Q35082688-5A3A63A0-CDC1-43DE-A17A-3901482E994BQ35198434-D171A543-5AC8-4DBC-A03A-2DD04509C936Q35964333-5DA0E774-406D-425A-9823-2A9E47215C20Q36118495-52F1A688-832C-42A3-91A2-9DEA0567324EQ36349034-19F6F4D7-737E-4212-894F-2F6C9EA068D9Q36412743-45F22552-FD2B-4A33-A93B-344EB5BD155AQ36432054-DF17D08C-AF15-45BA-98D0-6F45E9AAE904Q36498619-70C62CF7-9701-4232-BC29-54A3D5388044Q36498818-F071A1F6-99A7-478B-9715-1FBC20DD445FQ36626048-33CE45F8-6067-4E47-ACB4-7994D8FAD363Q36810808-DDAC99FF-F359-491C-8612-7B9DEE4F6567Q36893097-1C579D93-F18A-40B5-938E-3416BD81861BQ37181096-17E97244-A6DD-459E-8A06-42D0F5089444Q37420941-9DC40A40-FE46-47D7-9CE4-32454524650B
P2860
Ghost authorship in industry-initiated randomised trials
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Ghost authorship in industry-initiated randomised trials
@ast
Ghost authorship in industry-initiated randomised trials
@en
Ghost authorship in industry-initiated randomised trials
@en-gb
Ghost authorship in industry-initiated randomised trials
@nl
type
label
Ghost authorship in industry-initiated randomised trials
@ast
Ghost authorship in industry-initiated randomised trials
@en
Ghost authorship in industry-initiated randomised trials
@en-gb
Ghost authorship in industry-initiated randomised trials
@nl
altLabel
Ghost Authorship in Industry-Initiated Randomised Trials
@en
prefLabel
Ghost authorship in industry-initiated randomised trials
@ast
Ghost authorship in industry-initiated randomised trials
@en
Ghost authorship in industry-initiated randomised trials
@en-gb
Ghost authorship in industry-initiated randomised trials
@nl
P2860
P50
P3181
P1433
P1476
Ghost authorship in industry-initiated randomised trials
@en
P2093
An-Wen Chan
P2860
P3181
P356
10.1371/JOURNAL.PMED.0040019
P407
P577
2007-01-01T00:00:00Z